Physician profile
Ryan Mayer
NPI 1255793527
$26,730.84
in general payments reported to CMS, 2019-2025
13 companies · $854 in 2025
The $854 reported for 2025 was less than what a typical Orthopaedic Trauma provider received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,020 · 2020: $245 · 2021: $15K · 2022: $8,111 · 2023: $1,048 · 2024: $688 · 2025: $854.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,473 · Travel and Lodging: $116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,473.49 |
| Travel and Lodging | $116.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $10,181.12 | 2021 | |
| Smith+Nephew, INC. | $6,250.00 | 2021-2022 | |
| Stryker Corporation | $6,190.82 | 2019-2025 | Gamma, Pro, Pangea |
| Depuy Synthes Sales INC. | $1,255.67 | 2019-2022 | |
| Synthes Gmbh | $1,150.26 | 2022 | |
| Medinc of Texas | $528.33 | 2022-2025 | |
| Medical Device Business Services, INC. | $414.12 | 2019 | |
| Zimmer Biomet Holdings, INC. | $254.41 | 2019-2021 | |
| US Implant Solutions, LLC | $219.43 | 2024 | |
| Bone Support INC. | $132.16 | 2025 | Ceramentbone Void Filler, Cerament G |
| Globus Medical, INC. | $115.37 | 2022-2023 | Distal Femur Plate System |
| Biotissue Holdings INC. | $20.78 | 2022 | |
| Solventum Corporation | $18.37 | 2025 | V.A.C. Veraflo, V.A.C. Veraflo Cleanse Choice, Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Mayer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.